|
⚲
|
| SOV Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001484177 |
| Sale | 2010-02-11 ($1.0 M Offered, $0.2 M Sold) |
| Fund | |
| Phone | 9196012208 |
| Address | 101 Guymon Court Morrisville, 27560 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Himanshu Shah | |
| Om Dhingra | |
| Satinder Sethi | |
| Arun Shukla |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
NOR 100, a series of SAX Capital Series Fund III, LP
✚
|
0.0 | |
|
North Hudson Production Partners LP
✚
|
0.0 | |
|
Nomis Bay Ltd
✚
|
0.0 | |
|
NOMO Ventures SPV XIII, LLC
✚
|
0.0 | |
|
NOMO Ventures SPV XIV, LLC
✚
|
0.0 | |
|
NOMO Ventures SPV XV, LLC
✚
|
0.0 | |
|
Bates Stringer - Martin Hills Ranch LLC
✚
|
0.0 | |
|
BCOF FG LLC
✚
|
0.0 | |
|
Lauberhorn Opportunity I, LP
✚
|
0.0 | |
|
NOM Fund I, a series of JMWTX Investments, LP
✚
|
0.0 |